Exclusive
Most Read
Biogen’s new CEO, clear-eyed about company’s challenges, prepares to take the reins
Death of patient in closely watched Alzheimer’s trial raises concern about risk for some groups
Inside Michelle McMurry-Heath’s departure from BIO: Firings, internal clashes, and a pivotal job review
Large insurer’s decision to cover some prescription digital therapies may be a milestone for app makers
Researchers revive abandoned technique in effort to make artificial human eggs in a test tube
New details emerge about a U.S. scientist’s obscured role in the ‘CRISPR babies’ scandal
The Catholic hospital system Ascension is running a Wall Street-style private equity fund
All Coverage
advertisement
